MEDNAX, INC. 4
4 · MEDNAX, INC. · Filed Feb 17, 2017
Insider Transaction Report
Form 4
GABOS PAUL G
Director
Transactions
- Exercise/Conversion
Common Stock
2017-02-16$32.33/sh+10,668$344,843→ 21,923 total - Exercise/Conversion
Stock Options (Right to Buy)
2017-02-16$32.33/sh−10,668$344,843→ 0 totalExercise: $32.33From: 2010-11-01Exp: 2017-11-01→ Common Stock (10,668 underlying) - Exercise/Conversion
Common Stock
2017-02-16$27.71/sh+10,668$295,664→ 32,591 total - Sale
Common Stock
2017-02-16$69.63/sh−21,336$1,485,664→ 11,255 total - Exercise/Conversion
Stock Options (Right to Buy)
2017-02-16$27.71/sh−10,668$295,664→ 0 totalExercise: $27.71From: 2011-05-23Exp: 2018-05-23→ Common Stock (10,668 underlying)
Footnotes (1)
- [F1]The price reported in Column 4 is an weighted average price. These shares were sold in thirty-three (33) separate transactions with prices ranging from $69.4250 to $69.78 for an average weighted sales price of $69.6318. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.